A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
<h4>Background</h4>Chronic lymphocytic leukemia (CLL) is incurable through conventional chemoimmunotherapy regimens. Despite durable responses to front-line therapy and sustained remission rates in patients with CLL, a majority of patients eventually relapse in 5 years of initial treatme...
Saved in:
Similar Items
-
Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia
by: VV Strugov, et al.
Published: (2016-04-01) -
Pseudohyperkalemia in Patients with Chronic Lymphocytic Leukemia
by: Stephen I. Rifkin
Published: (2011-01-01) -
Meningeal involvement in chronic lymphocytic leukemia
by: S. N. Menshakova, et al.
Published: (2022-11-01) -
Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Neutrophils unveiled in chronic lymphocytic leukemia
by: Sheighlah McManus, et al.
Published: (2025-08-01)